Skip to main content

Agentix Corp.

corporate_fare Company Profile

Agentix Corp.

AGTX·OTC·Life Sciences·CIK 0001603345

Agentix Corp. is a clinical development stage corporation focused on pharmaceutical treatments in the metabolic disease space. The company was incorporated in Nevada on April 18, 2013, and its fiscal year ends on March 31. Effective June 17, 2019, the company changed its name from FairWind Energy, Inc. to Agentix Corp. to reflect its new business focus. Until recently, Agentix Corp.'s business plan involved the design, engineering, and manufacturing of composite products, specifically supplying products to the oil and gas industry. However, on May 28, 2020, the company entered into a Share Exchange Agreement with GSL Healthcare, Inc., a Nevada corporation, and its two common stockholders. The closing occurred on June 1, 2020. Under this agreement, Agentix Corp. issued 27,932,271 shares of its common stock in exchange for all outstanding common stock of GSL Healthcare. As a result, the two former GSL Healthcare shareholders now own approximately 88.0% of Agentix Corp.'s issued common stock, and GSL Healthcare is a wholly-owned subsidiary. Following the Share Exchange Agreement, Agentix Corp. plans to focus its business efforts on developing and commercializing novel therapeutics to treat metabolic disease. Its primary objective is to develop two key assets specifically designed not to cross the blood-brain barrier, meaning they are "peripherally-restricted." In September 2022, the company established Agentix Australia Pty Ltd, a subsidiary in Australia, to conduct development activities for these two key assets. This subsidiary is operational and participates in a tax rebate program that reimburses 43.5% of expenses for biotechnology and/or pharmaceutical development activities conducted in Australia. Agentix Corp. has not yet generated or realized meaningful revenues from its current business.

Agentix Corp. (OTC:AGTX) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 4 items for AGTX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-06, rated 8/10. Across its 4 most recent items scored 7 or higher, the top rating is 9/10, with 3 rated 8 or above. Recent SEC coverage for AGTX spans 10-Q, 10-K.

Recent high-impact activity:

  • Agentix Q2: $1,312 Cash, $3.8M Working Capital Hole, Going Concern Intact
  • Agentix Corp. Reports $0 Revenue, $486K Net Loss for FY26
  • Agentix Corp. Discloses Substantial Going Concern Doubt, Zero Revenue, and Material Internal Control Weaknesses in Annual Report
  • Agentix Corp. Discloses Going Concern Doubt, Ineffective Controls, and Critical Liquidity Issues

Financial Snapshot

Fiscal year ended March 31, 2026
Net Income
-$485.64K
Diluted EPS
-$0.01
Op. Cash Flow
-$108.53K
Operating Income
-$445.19K
Cash & Equivalents
$771
Debt / Equity
0.00×
Shares Outstanding
40.07M sh
Source: 10-K · filed 2026-06-30 · accession 0001477932-26-004133

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 9,518 shares in AGTX as of the October 30, 2026 settlement, a 52777.8% increase from the prior period — about 1.0 days to cover at its recent average daily volume.

Short interest (bi-monthly positions)9,518 shares as of October 30, 2026
Change vs prior period▲ 52777.8%
Days to cover1.00 at avg daily volume of 138,200

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with A →
$0.0336 -0.30% today
52-week range · as of 2026-11-06 $0.0142 – $0.46
Market cap
$1.35M
Volume
100 (0.0× avg)
3-mo avg 53.5K
Live data · 2026-11-22 12:41 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed AGTX - Latest Insights

AGTX
Nov 06, 2026, 10:44 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.0337
Real-time Price: $0.0336 info
Change: Low Volume info
Market Cap: $1.346M info
AGTX
Jul 01, 2026, 6:05 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $0.020
Real-time Price: $0.0336 info
Change: Low Volume info
Market Cap: $1.346M info
AGTX
Jun 30, 2026, 7:36 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $0.020
Real-time Price: $0.0336 info
Change: Low Volume info
Market Cap: $1.346M info
AGTX
Feb 17, 2026, 1:26 PM EST
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.04198
Real-time Price: $0.0336 info
Change: Low Volume info
Market Cap: $1.346M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets